FDA Must Not Be Allowed to Make Affordable Breathing Aids UNAVAILABLE to 3 Million U.S. Citizens

  • af: Beau Cox
  • mottagare: House and Senate Oversight Committees that monitor the FDA

The EPA has BANNED a very affordable over the counter medicine - PRIMATENE MIST- that gave instant Emergency relief to 3 Million users with breathing problems. REASON / EXCUSE:The convenient container, that held the liquid which was turned into a mist, created a gas that the FDA said was depleting the Ozone Layer. It was then and still is quite obvious that this was a stretched excuse to eliminate the product from the non-prescription / over the counter drug market. The small bottle which contained PRIMITENE MIST sold for around $19 - $22. The next best alternatives / replacement was Prescription Inhalers that sell for $53 minimum and often do not work. The most advanced Prescription meds, with the Dr. visit included to obtain the prescription, can cost - at a minimum $300 - for a monthly supply.  

After PRIMITENE was taken off the market, another product made its debut that - albeit awkward to carry and use - was available as an Emergency Inhaler and was priced reasonably. Much more affordable than various prescription inhalers.
Now the FDA - without warning - has made that manufacturer stop making the EMERGENCY Inhaler while they, the FDA,  determines whether IT should be a prescribed medicine.

In essence, the FDA's actions are a very obvious method to - FORCE - 3 Million people off of legitimate and effective EMERGENCY inhalers on to More expensive prescription inhalers.

Bottom Line / Reason for BOTH actions - improve and ensure Prescription Drug Company Profits.

Where Is OUR LOBBYIST for the 3 Million of us with Breathing Problems .

Skriv under
Skriv under
JavaScript er deaktiveret på din computer. Vores websted fungerer muligvis ikke korrekt, hvis ikke JavaScript er aktiveret.

fortrolighedspolitik

ved at underskrive accepterer du Care2's vilkår for tjeneste
Du kan til enhver tid administrere dine e-mailabonnementer.

Har problemer med at underskrive dette? Giv os besked.